SABR

Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)

Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management

Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC

UroLift System With SAbR for Prostate Cancer and BPH

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors

Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer

Low and Intermediate Risk OliGometastatic ColoREctal CancEr PatieNts Treated with Stereotactic ABlative Radiotherapy

Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC

Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases

Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer

Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease

Prostate PMSABR Study

Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma

Stereotactic MRI-Guided Radiation for Localized Prostate Cancer

SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients